New antimicrobial compounds from a marine-derived Bacillus sp

Area of Science:

• Marine microbiology
• Natural product chemistry
• Antimicrobial drug discovery

Background:

• Marine microorganisms, particularly bacteria, are a rich source of novel bioactive compounds.
• The search for new antimicrobial agents is crucial due to rising antimicrobial resistance.

Purpose of the Study:

• To isolate and characterize new metabolites from a marine Bacillus species.
• To evaluate the antimicrobial potential of the isolated compounds.

Main Methods:

• Isolation of compounds from bacterial culture broth.
• Structure elucidation using spectroscopic data interpretation (e.g., NMR, MS).
• Determination of absolute configurations via modified Mosher's method and literature comparison.

Main Results:

• Five new compounds were identified: three macrolactones (macrolactins X-Z) and two hydroxy unsaturated fatty acids (linieodolides A and B).
• A known metabolite, macrolactinic acid, was also isolated.
• Compounds 1-6 exhibited moderate to potent inhibitory activity against selected pathogenic microorganisms, with minimum inhibitory concentrations (MICs) ranging from 8 to 128 μg/mL.

Conclusions:

• The marine Bacillus sp. produces a diverse array of bioactive macrolactones and fatty acids.
• The newly discovered compounds possess significant antimicrobial properties, warranting further investigation for potential therapeutic applications.